Basic Tutorials

by Jimmyjay86

Buy xenical orlistat 120 mg

Getting an Enemy to Follow Waypoints

Guide to Player Index

Making an NPC Join Your Team

Making Clips

Exit Grid

Exit Grid Switch

Random Attack in Map

Speaking Entities

Comprehensive Guide to Using Photoshop to Create a Raw File

Making Ladders:

1. Go to the "View" pull down menu at the top. Check "Show Tile Bounding Box".

2. Tiles for ladders are at Generic Tiles/Ladders. The segments show up very small, so in the "Tile List Scale" field change the number from 0.5 to 5 and hit enter. Pick the segment you want to use.

3. If your ground level is at 0 and your roof level is at 13, then start at level 13. Align the first segement next to the roof and click the left mouse button to position the segment. From now on be careful not to shift the mouse from that position.

4. Hit the Page-Down key to move down a level and gently hit the left mouse button again. Keep doing this until you get to level 1. If you have a mouse or keyboard with a thumb wheel this process will be much easier.

5. Go to the "Select" field at the top and while holding down the shift key, left click each segment and Page-Up to click the next segment. Do this for the whole ladder and the bounding box will have a blue tint to it.

6. Go to the "Tools" button and click the "Climbable" option.

7. That is all - it should work perfectly. If not, practice a few times.

Getting an Enemy to Follow Waypoints:

1. In the Player Setup dialogue box, go to the player that you want to move. On the right side, click the "AI Setup" box. Make the "Controller Type" set for Waypoints. Enter 5 for the "Move Type Priority" and for the "Move Target Tag" type in Enemy-way. Leave everything else as is for now but note that if you hold down the left mouse button in the box and move the mouse upwards, you can see more options.

2. Place your enemy entity and make sure that he has a player index of 2.

3. Now place the waypoint - set the player index back to 0 and where it says "Tag", type in Enemy-way. The waypoint entity is found under the "misc" directory. Place as many as you need.

4. Click on Entity Edit and click the first waypoint you want to go to. On the left side menu slide down to where it says "Waypoint Index" and type in 1, the next entity is "Next Waypoint List" - type in 2. Do this for all of the waypoints and for the last one, the "Next Waypoint List" should be 1.

5. That should work, if it doesn't let me know.

Guide to the Player Index:

To set up a single player mission you are going to need a player character(PC) to control and also enemies or other non-player characters(NPC's) to interact with. Here is how to set them up:

1. The first step is to click on the "Level" button at the top of the level editor. On the left side screen there should now be an option button for "Player" - click it. This opens the "Player Setup" dialogue box. The default settings are "0. Scenery" and "1. Humans". You want to "Add" another Player Index - "2. Enemy". Under "Name", type "Enemy" and for type you want to use Computer. The team you can pick "2" and then click ok.

2. Now click on the "Team" button on the left side which will bring you to the "Team Setup". Highlight Team 1 and type in the name of your team - "BOS" or whatever and the same for Team 2 - "Enemy". Where all the green squares are, left-click the appropriate boxes to make them enemies or right-click them to make them friends. So in the first row, left click on the box in column 2 until you get a value of -10 and the same for Row 2, Column 1.

3. Now you want to insert the entities for your enemies. At the top of the screen click on the "Entity" box. A new menu will appear on the left side with a directory of the entities. In the Player field enter the number 2 and hit enter. Don't enter anything in the Tag field for now. Click on the directory for Actors and choose the character you want to use or find an entity that you have already created with the entity editor. Then just place him/her wherever you'd like. If you immediately click the entity editor box you can edit this entity. You may want to customize the looks of a generic figure or rotate him to face a particular direction or add things to his inventory.

4. If you want to add a PC that you control, do the same thing except put him/her/it under Player Index 1.

Making an NPC Join Your Team:

1. In the speech editor, click the "Add" button. The name of the speech goes under the "Remove" button. In the Random 1 field choose the node to assign to this speech. And under that enter an event name like "NPCspoke1".

2. For the trigger condition use "Speech Occured". Here you choose the speech event from above - "NPCspoke1".

3. For the trigger action use "Change Player". Pick the tag name you used for the entity from the list for the Unit. Then you want to change him to Player 1.

Making Clips:

You have to select a whole building first - all of it's levels, stairs, walls, roof, etc. Hold down the shift key when selecting additional things. When you have the whole thing, hit ctrl-c to copy it to the clipboard. Then click the 'save clip' button to save it with whatever name you want. Then when you want to load it, click 'load clip' and move the cursor someplace and hit ctrl-v to paste it. Paste it at the highest level that the building is in. So if the roof is at level 13, then paste it in there. It takes a little practice - don't expect to get it right the first or second time. And if you screw up, hit ctrl-z to undo.

Exit Grid:

To make an exit grid is easy - just select the tiles you want and go to the tools pull-down menu and click 'exit'. Now it won't show up green right away, so scroll your screen over and then back - voila, green exit-grid. To make the grid pop up at the appropriate time use a trigger. Set the action to 'Toggle Exit Grid' and the condition to whatever.

Exit Grid Switch:

1. Create your exit grid by selecting the tiles and clicking the Tools pull down menu and clicking 'Exit'.

2. Click on entity and find the switch you want to use. Give it a 'Tag Name', 'exit' for example.

3. Create a new trigger with a new condition.

Object Script State of 'exit'

4. Create a new action.

Turn Exit Grids 'On'

Random Attack in a Map:

Just set up a small zone on the map and have a NPC wander around with way points. Whenever your PC and the NPC are in the zone at the same time, he will start attacking you. Everywhere else, he will just ignore you. Use a trigger to set it up:


Player 1 has more than 0 alive at zone 'attack'

Player 3 has more than 0 alive at zone 'attack'


Change units Player 3 to Player 4

Keep player 3 set as a neutral team and player 4 as an enemy team.

Where to buy proscar in canada

Proscar is used for treating urinary problems caused by an enlarged prostate gland (benign prostatic hyperplasia).

Buy proscar tablets Celgene Celgene is an innovative company whose portfolio of medicines targets the genetic disorders of Alzheimer's disease, Parkinson's multiple sclerosis, heart cancer and rheumatoid arthritis. These diseases are characterized by abnormal protein accumulation, which is associated with the onset of progressive cognitive decline. The company has been investing in the development of its investigational medicines since 2007. AstraZeneca AstraZeneca is a leading global specialty pharmaceutical company with a portfolio of over 5,000 innovative medicines and is dedicated to helping customers solve their toughest challenges. The company is focused on development of new therapies, both in preclinical and clinical research, for patients from a range of diseases, including Alzheimer's disease, cardiovascular conditions, cancer, arthritis, diabetes, infectious disease, rheumatoid systemic lupus erythematosus and more. Since its founding in 1874, AstraZeneca has been a leader in scientific research and development, the company's focus on patient care has continued to inform its research and development. Bayer Bayer is one of the leading global pharmaceutical companies and has been an innovator in the treatment of rare diseases since its founding in 1901. The company has developed a significant product pipeline across more than 80 diseases and conditions, including several on the Company's Discovery Pipeline and several of its therapeutic candidates. The company has grown significantly in the past few years, with addition of Regeneron to its portfolio therapeutic candidates as well acquisitions of MedImmune and Astellas, to name a few of its recent acquisitions. Bayer plans to continue its development and commercialization of Discovery pipeline, including the and development of new molecules therapeutics that are in development for rare diseases and conditions. Celgene is one of the world's leading biopharmaceutical companies. company manufactures proscar generic online and sells an expanding portfolio of branded pharmaceuticals, including the Celgene Corporation's leading line of immuno-oncology medicines and products. Celgene is part of Corporation; it was founded by George Herbert Walker, and is headquartered in San Diego, California. Celgene Pharmaceuticals had sales of approximately $6.2 billion and gross revenues of approximately $6.4 billion for its most recently fiscal year ended December 31, 2016. Celgene's leading drug candidates are sold in over 75 countries and are approved marketed in over 100 countries and regions in the world. Eli Lilly 24h drugstore toronto and Company Eli Lilly and Company (formerly Aspirin, Inc.) is a major global provider of prescription, over-the-counter, healthcare products. The company's products include drugs and medical device products for a variety of conditions ranging from cancer and cardiovascular disease through cardiovascular, respiratory, and allergy-based diseases. More than 1 in 5 Americans take one of its medicines. For additional information, visit Janssen Janssen's products include a variety of generic and branded drug products, including medicines and vaccines for a wide range of conditions. The company provides these products to healthcare providers, primarily through its Janssen unit, which is headquartered in Denmark. The company has also developed several investigational drugs. In late 2016, Janssen an